NEW ORLEANS, La. (NOLA NOW) - For those living with traumatic brain injuries, recovery often feels like an battle struggling with memory loss, chronic headaches, cognitive decline, and emotional instability. While standard medical care focuses on managing symptoms, Harch Hyperbaric Oxygen Therapy (HBOT) is designed to target the underlying disease processes that contribute to medical and neurological conditions.
Whether from a sports injury or a car accident, traumatic brain injuries impact people of all ages. Traumatic brain injuries, ranging from mild concussions to severe physical trauma, disrupt vital neural pathways and cerebral blood flow.
According to Dr. Paul G. Harch, hyperbaric oxygen therapy addresses this core damage by delivering concentrated oxygen inside a pressurized chamber. This treatment has been shown to help service members, veterans, and those effected after 9/11, from blast induced traumatic brain injury.
Imaging in published research studies has shown improvement in many patients with chronic concussion after the first HBOT.
Clinical Evidence vs. Traditional Care
ADVERTISEMENT
Dr. Harch says HBOT is backed by compelling clinical evidence demonstrating outcomes that equal or exceed standard supportive treatments:
- Acute Severe TBI: Multiple clinical studies demonstrate that HBOT can reduce mortality rates in acute severe TBI patients by up to 60%, an outcome rarely matched in acute neurological trauma.
- Chronic and Subacute Recovery: For patients who have plateaued with conventional therapies months or years post-injury, HBOT has produced measurable functional and cognitive gains. Mild TBI patients regularly experience marked or near-complete symptom relief within 40 or fewer sessions.
- Objective Brain Scans: Pre- and post-treatment functional imaging (such as SPECT scans) shows visible increases in cerebral blood flow and neurological restoration.
HBOT brings new life to patients who have lost theirs. Get treatment by a leading expert to support your recovery journey by clicking here or calling 504-309-4948.
HBOT has not been approved by the Food and Drug Administration for treatment of stroke, long COVID, or Cerebral Palsy . The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition.
Copyright 2026 WVUE. All rights reserved.